Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2016
Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control studyKathrine B Sondergaard, Peter Weeke, Mads Wissenberg, et al.Journal of the American College of Cardiology|January 22, 2011
Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort studyJonas B Olesen, Gunnar H Gislason, Mette G Charlot, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 20, 2014
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013Jonas Bjerring Olesen, Rikke Sørensen, Morten Lock Hansen, et al.International Journal of Cardiology. Heart & Vasculature|June 6, 2022
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controlsCharlotte Andersson, Morten Schou, Brian Schwartz, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on StatinsWei-Qi Wei, Qiping Feng, Peter Weeke, et al.Resuscitation|November 10, 2011
Hospital admissions and pharmacotherapy before out-of-hospital cardiac arrest according to agePeter Weeke, Fredrik Folke, Gunnar H Gislason, et al.Plos One|August 25, 2017
Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillationDaniela Husser, Laura Ueberham, Gerhard Hindricks, et al.Nutrition & Metabolism|October 16, 2009
Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCharlotte Andersson, Peter Weeke, Bente Brendorp, et al.BMC Endocrine Disorders|February 27, 2010
The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodPeter Weeke, Charlotte Andersson, Emil L Fosbøl, et al.Circulation|September 17, 2013
Automated external defibrillators inaccessible to more than half of nearby cardiac arrests in public locations during evening, nighttime, and weekendsCarolina Malta Hansen, Mads Wissenberg, Peter Weeke, et al.Pageof 6